ACNT ASCENT INDUSTRIES CO.

Nasdaq Chemicals & Allied Products DE CIK: 0000095953
AI RATING
SELL
72% Confidence

Investment Thesis

ACNT is operationally distressed with negative profitability, declining revenue (-7.2% YoY), and negative free cash flow (-$5.8M) indicating fundamental business deterioration. While the company maintains a fortress balance sheet with $47.8M cash and zero debt, the unsustainable cash burn and lack of positive operating metrics reflect a deteriorating business without clear turnaround evidence.

Strengths

  • + Strong balance sheet with zero long-term debt and $81.6M stockholders' equity
  • + Excellent liquidity position with $47.8M cash equivalents and 8.69x current ratio
  • + Net loss improvement of 106.4% YoY suggests potential stabilization of operational bleeding

Risks

  • ! Persistent operating losses with -12.2% operating margin and -$5.4M operating cash flow
  • ! Revenue declining 7.2% YoY with thin 14.5% gross margins providing no operational cushion
  • ! Negative free cash flow of -$5.8M (-30.1% FCF margin) is unsustainable and will deplete reserves

Key Metrics to Watch

Financial Metrics

Revenue
19.4M
Net Income
-2.0M
EPS (Diluted)
$-0.21
Free Cash Flow
-5.9M
Total Assets
102.6M
Cash
47.8M

Profitability Ratios

Gross Margin 14.5%
Operating Margin -12.2%
Net Margin -10.2%
ROE -2.4%
ROA -1.9%
FCF Margin -30.1%

Balance Sheet & Liquidity

Current Ratio
8.69x
Quick Ratio
7.82x
Debt/Equity
0.00x
Debt/Assets
20.4%
Interest Coverage
-18.71x
Long-term Debt
0.0
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-08T08:52:04.069777 | Data as of: 2026-03-31 | Powered by Claude AI